pharmaobservatory 0.1.5 → 0.1.6

This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
Files changed (307) hide show
  1. checksums.yaml +4 -4
  2. data/README.md +114 -7
  3. data/docs/BiomarkerAssayEvidenceResponse.md +58 -0
  4. data/docs/{BiomarkerCdxAssertionsResponseBuild.md → BiomarkerAssayEvidenceResponseBuild.md} +2 -2
  5. data/docs/{BiomarkerCdxAssertionsResponseFreshness.md → BiomarkerAssayEvidenceResponseFreshness.md} +2 -2
  6. data/docs/{BiomarkerCdxAssertionsResponseScope.md → BiomarkerAssayEvidenceResponseScope.md} +2 -2
  7. data/docs/BiomarkerAssayEvidenceRow.md +68 -0
  8. data/docs/BiomarkerAssayWhitespaceResponse.md +58 -0
  9. data/docs/BiomarkerAssayWhitespaceRow.md +66 -0
  10. data/docs/BiomarkerBqpAssertionsResponse.md +3 -3
  11. data/docs/BiomarkerCdxAssertionsResponse.md +3 -3
  12. data/docs/BiomarkerEvidenceResponse.md +3 -3
  13. data/docs/BiomarkerLiteratureResponse.md +3 -3
  14. data/docs/BiomarkerPublishingCompaniesResponse.md +3 -3
  15. data/docs/BiomarkerPublishingCompaniesRow.md +9 -1
  16. data/docs/BiomarkerRelationsResponse.md +3 -3
  17. data/docs/BiomarkerSampleCoverageResponse.md +3 -3
  18. data/docs/BiomarkerSamplePrevalenceResponse.md +3 -3
  19. data/docs/BiomarkerValidationResponse.md +3 -3
  20. data/docs/BiomarkerVariantMentionsResponse.md +3 -3
  21. data/docs/BiomarkersApi.md +160 -0
  22. data/docs/BiomarkersRecord.md +2 -2
  23. data/docs/BiomarkersResponse.md +3 -3
  24. data/docs/BiomarkersRow.md +2 -0
  25. data/docs/CellLinesRecord.md +2 -2
  26. data/docs/CellLinesResponse.md +3 -3
  27. data/docs/CompaniesApi.md +246 -0
  28. data/docs/CompaniesRecord.md +2 -2
  29. data/docs/CompaniesResponse.md +3 -3
  30. data/docs/CompaniesRow.md +1 -1
  31. data/docs/CompanyAssetsResponse.md +3 -3
  32. data/docs/CompanyFundingEventsResponse.md +3 -3
  33. data/docs/CompanyFundingEventsRow.md +1 -1
  34. data/docs/CompanyFundingSummaryResponse.md +3 -3
  35. data/docs/CompanyMembersResponse.md +3 -3
  36. data/docs/CompanyProgramsResponse.md +3 -3
  37. data/docs/CompanyTargetsResponse.md +3 -3
  38. data/docs/CompanyTargetsRow.md +5 -1
  39. data/docs/ConditionAdverseEventsResponse.md +3 -3
  40. data/docs/ConditionBurdenResponse.md +3 -3
  41. data/docs/ConditionDeliveryResponse.md +3 -3
  42. data/docs/ConditionDrugsResponse.md +3 -3
  43. data/docs/ConditionPrevalenceResponse.md +3 -3
  44. data/docs/ConditionPrevalenceRow.md +1 -1
  45. data/docs/ConditionPublicationsResponse.md +3 -3
  46. data/docs/ConditionRecruitmentByPhaseResponse.md +58 -0
  47. data/docs/ConditionRecruitmentByPhaseRow.md +50 -0
  48. data/docs/ConditionRecruitmentDurationResponse.md +58 -0
  49. data/docs/ConditionRecruitmentDurationRow.md +86 -0
  50. data/docs/ConditionSitesResponse.md +3 -3
  51. data/docs/ConditionTrialStartForecastResponse.md +58 -0
  52. data/docs/ConditionTrialStartForecastRow.md +70 -0
  53. data/docs/ConditionTrialsResponse.md +3 -3
  54. data/docs/ConditionTrialsRow.md +1 -1
  55. data/docs/ConditionsApi.md +240 -0
  56. data/docs/ConditionsRecord.md +2 -2
  57. data/docs/ConditionsRecordAttributes.md +3 -1
  58. data/docs/ConditionsResponse.md +3 -3
  59. data/docs/DrugPatentCliffResponse.md +3 -3
  60. data/docs/InstitutionalHoldingsResponse.md +3 -3
  61. data/docs/InstitutionalHoldingsRow.md +7 -1
  62. data/docs/InvestorFundsResponse.md +58 -0
  63. data/docs/InvestorFundsRow.md +24 -0
  64. data/docs/InvestorPortfolioResponse.md +58 -0
  65. data/docs/InvestorPortfolioRow.md +42 -0
  66. data/docs/InvestorPrivateFundsResponse.md +58 -0
  67. data/docs/InvestorPrivateFundsRow.md +44 -0
  68. data/docs/InvestorsApi.md +633 -0
  69. data/docs/InvestorsRecord.md +38 -0
  70. data/docs/InvestorsResponse.md +58 -0
  71. data/docs/InvestorsRow.md +54 -0
  72. data/docs/LegalEntitiesApi.md +240 -0
  73. data/docs/LegalEntitiesRecord.md +2 -2
  74. data/docs/LegalEntitiesResponse.md +3 -3
  75. data/docs/LegalEntitiesRow.md +1 -1
  76. data/docs/ManagersApi.md +233 -0
  77. data/docs/ManagersRecord.md +38 -0
  78. data/docs/ManagersResponse.md +58 -0
  79. data/docs/ManagersRow.md +46 -0
  80. data/docs/OrgDisclosuresResponse.md +58 -0
  81. data/docs/OrgDisclosuresRow.md +56 -0
  82. data/docs/OrgRelationshipsResponse.md +58 -0
  83. data/docs/OrgRelationshipsRow.md +68 -0
  84. data/docs/OwnershipPositionsResponse.md +3 -3
  85. data/docs/OwnershipPositionsRow.md +16 -14
  86. data/docs/PdufaDatesResponse.md +3 -3
  87. data/docs/SiteBedsYearlyResponse.md +3 -3
  88. data/docs/SiteCroTrialsResponse.md +3 -3
  89. data/docs/SiteHospitalsResponse.md +3 -3
  90. data/docs/SiteInvestigatorsResponse.md +3 -3
  91. data/docs/SiteTrialConditionsResponse.md +3 -3
  92. data/docs/SiteTrialDrugsResponse.md +3 -3
  93. data/docs/SiteTrialsResponse.md +3 -3
  94. data/docs/SitesRecord.md +2 -2
  95. data/docs/SitesResponse.md +3 -3
  96. data/docs/SponsorRecruitmentByPhaseResponse.md +3 -3
  97. data/docs/SponsorRecruitmentDurationResponse.md +3 -3
  98. data/docs/SponsorTrialStartForecastResponse.md +3 -3
  99. data/docs/SponsorTrialsResponse.md +3 -3
  100. data/docs/SponsorTrialsRow.md +1 -1
  101. data/docs/SupplierCapabilityEsgResponse.md +58 -0
  102. data/docs/SupplierCapabilityEsgRow.md +64 -0
  103. data/docs/SupplierServicesResponse.md +58 -0
  104. data/docs/SupplierServicesRow.md +30 -0
  105. data/docs/SupplierSitesResponse.md +58 -0
  106. data/docs/SupplierSitesRow.md +42 -0
  107. data/docs/SuppliersApi.md +313 -0
  108. data/docs/SuppliersRecord.md +38 -0
  109. data/docs/SuppliersResponse.md +58 -0
  110. data/docs/SuppliersRow.md +76 -0
  111. data/docs/TargetAssociationsResponse.md +58 -0
  112. data/docs/TargetAssociationsRow.md +26 -0
  113. data/docs/TargetCrowdingResponse.md +58 -0
  114. data/docs/TargetCrowdingRow.md +30 -0
  115. data/docs/TargetDrugsResponse.md +58 -0
  116. data/docs/TargetDrugsRow.md +38 -0
  117. data/docs/TargetEvidenceResponse.md +58 -0
  118. data/docs/TargetEvidenceRow.md +52 -0
  119. data/docs/TargetPatentMentionsResponse.md +58 -0
  120. data/docs/TargetPatentMentionsRow.md +34 -0
  121. data/docs/TargetProgramsResponse.md +58 -0
  122. data/docs/TargetProgramsRow.md +58 -0
  123. data/docs/TargetPublicationsResponse.md +58 -0
  124. data/docs/TargetPublicationsRow.md +32 -0
  125. data/docs/TargetRegulatoryPrecedentResponse.md +58 -0
  126. data/docs/TargetRegulatoryPrecedentRow.md +38 -0
  127. data/docs/TargetTrialsResponse.md +58 -0
  128. data/docs/TargetTrialsRow.md +46 -0
  129. data/docs/TargetsApi.md +1033 -0
  130. data/docs/TargetsRecord.md +38 -0
  131. data/docs/TargetsResponse.md +58 -0
  132. data/docs/TargetsRow.md +68 -0
  133. data/docs/TrialAdverseEventsResponse.md +3 -3
  134. data/docs/TrialChangesResponse.md +3 -3
  135. data/docs/TrialDeliveryResponse.md +3 -3
  136. data/docs/TrialDemographicsResponse.md +3 -3
  137. data/docs/TrialDrugClassesResponse.md +58 -0
  138. data/docs/TrialDrugClassesRow.md +28 -0
  139. data/docs/TrialDrugsResponse.md +3 -3
  140. data/docs/TrialEnrollmentHistoryResponse.md +3 -3
  141. data/docs/TrialEnrollmentRateResponse.md +3 -3
  142. data/docs/TrialExtractedEndpointsResponse.md +3 -3
  143. data/docs/TrialKolsResponse.md +58 -0
  144. data/docs/TrialKolsRow.md +32 -0
  145. data/docs/TrialOutcomeMeasuresResponse.md +3 -3
  146. data/docs/TrialResearchPaymentsResponse.md +58 -0
  147. data/docs/TrialResearchPaymentsRow.md +44 -0
  148. data/docs/TrialSiteHistoryResponse.md +58 -0
  149. data/docs/TrialSiteHistoryRow.md +50 -0
  150. data/docs/TrialSitesResponse.md +3 -3
  151. data/docs/TrialsApi.md +320 -0
  152. data/docs/TrialsRecord.md +2 -2
  153. data/docs/TrialsResponse.md +3 -3
  154. data/lib/pharmaobservatory/api/biomarkers_api.rb +168 -0
  155. data/lib/pharmaobservatory/api/companies_api.rb +273 -0
  156. data/lib/pharmaobservatory/api/conditions_api.rb +252 -0
  157. data/lib/pharmaobservatory/api/investors_api.rb +665 -0
  158. data/lib/pharmaobservatory/api/legal_entities_api.rb +252 -0
  159. data/lib/pharmaobservatory/api/managers_api.rb +245 -0
  160. data/lib/pharmaobservatory/api/suppliers_api.rb +329 -0
  161. data/lib/pharmaobservatory/api/targets_api.rb +1085 -0
  162. data/lib/pharmaobservatory/api/trials_api.rb +336 -0
  163. data/lib/pharmaobservatory/models/biomarker_assay_evidence_response.rb +478 -0
  164. data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_build.rb → biomarker_assay_evidence_response_build.rb} +3 -3
  165. data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_freshness.rb → biomarker_assay_evidence_response_freshness.rb} +3 -3
  166. data/lib/pharmaobservatory/models/{biomarker_cdx_assertions_response_scope.rb → biomarker_assay_evidence_response_scope.rb} +3 -3
  167. data/lib/pharmaobservatory/models/biomarker_assay_evidence_row.rb +506 -0
  168. data/lib/pharmaobservatory/models/biomarker_assay_whitespace_response.rb +478 -0
  169. data/lib/pharmaobservatory/models/biomarker_assay_whitespace_row.rb +499 -0
  170. data/lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb +3 -3
  171. data/lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb +3 -3
  172. data/lib/pharmaobservatory/models/biomarker_evidence_response.rb +3 -3
  173. data/lib/pharmaobservatory/models/biomarker_literature_response.rb +3 -3
  174. data/lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb +3 -3
  175. data/lib/pharmaobservatory/models/biomarker_publishing_companies_row.rb +49 -5
  176. data/lib/pharmaobservatory/models/biomarker_relations_response.rb +3 -3
  177. data/lib/pharmaobservatory/models/biomarker_sample_coverage_response.rb +3 -3
  178. data/lib/pharmaobservatory/models/biomarker_sample_prevalence_response.rb +3 -3
  179. data/lib/pharmaobservatory/models/biomarker_validation_response.rb +3 -3
  180. data/lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb +3 -3
  181. data/lib/pharmaobservatory/models/biomarkers_record.rb +2 -2
  182. data/lib/pharmaobservatory/models/biomarkers_response.rb +3 -3
  183. data/lib/pharmaobservatory/models/biomarkers_row.rb +12 -1
  184. data/lib/pharmaobservatory/models/cell_lines_record.rb +2 -2
  185. data/lib/pharmaobservatory/models/cell_lines_response.rb +3 -3
  186. data/lib/pharmaobservatory/models/companies_record.rb +2 -2
  187. data/lib/pharmaobservatory/models/companies_response.rb +3 -3
  188. data/lib/pharmaobservatory/models/companies_row.rb +1 -1
  189. data/lib/pharmaobservatory/models/company_assets_response.rb +3 -3
  190. data/lib/pharmaobservatory/models/company_funding_events_response.rb +3 -3
  191. data/lib/pharmaobservatory/models/company_funding_events_row.rb +1 -1
  192. data/lib/pharmaobservatory/models/company_funding_summary_response.rb +3 -3
  193. data/lib/pharmaobservatory/models/company_members_response.rb +3 -3
  194. data/lib/pharmaobservatory/models/company_programs_response.rb +3 -3
  195. data/lib/pharmaobservatory/models/company_targets_response.rb +3 -3
  196. data/lib/pharmaobservatory/models/company_targets_row.rb +27 -5
  197. data/lib/pharmaobservatory/models/condition_adverse_events_response.rb +3 -3
  198. data/lib/pharmaobservatory/models/condition_burden_response.rb +3 -3
  199. data/lib/pharmaobservatory/models/condition_delivery_response.rb +3 -3
  200. data/lib/pharmaobservatory/models/condition_drugs_response.rb +3 -3
  201. data/lib/pharmaobservatory/models/condition_prevalence_response.rb +3 -3
  202. data/lib/pharmaobservatory/models/condition_prevalence_row.rb +1 -1
  203. data/lib/pharmaobservatory/models/condition_publications_response.rb +3 -3
  204. data/lib/pharmaobservatory/models/condition_recruitment_by_phase_response.rb +478 -0
  205. data/lib/pharmaobservatory/models/condition_recruitment_by_phase_row.rb +399 -0
  206. data/lib/pharmaobservatory/models/condition_recruitment_duration_response.rb +478 -0
  207. data/lib/pharmaobservatory/models/condition_recruitment_duration_row.rb +597 -0
  208. data/lib/pharmaobservatory/models/condition_sites_response.rb +3 -3
  209. data/lib/pharmaobservatory/models/condition_trial_start_forecast_response.rb +478 -0
  210. data/lib/pharmaobservatory/models/condition_trial_start_forecast_row.rb +509 -0
  211. data/lib/pharmaobservatory/models/condition_trials_response.rb +3 -3
  212. data/lib/pharmaobservatory/models/condition_trials_row.rb +1 -1
  213. data/lib/pharmaobservatory/models/conditions_record.rb +2 -2
  214. data/lib/pharmaobservatory/models/conditions_record_attributes.rb +13 -4
  215. data/lib/pharmaobservatory/models/conditions_response.rb +3 -3
  216. data/lib/pharmaobservatory/models/drug_patent_cliff_response.rb +3 -3
  217. data/lib/pharmaobservatory/models/institutional_holdings_response.rb +3 -3
  218. data/lib/pharmaobservatory/models/institutional_holdings_row.rb +35 -2
  219. data/lib/pharmaobservatory/models/investor_funds_response.rb +478 -0
  220. data/lib/pharmaobservatory/models/investor_funds_row.rb +256 -0
  221. data/lib/pharmaobservatory/models/investor_portfolio_response.rb +478 -0
  222. data/lib/pharmaobservatory/models/investor_portfolio_row.rb +357 -0
  223. data/lib/pharmaobservatory/models/investor_private_funds_response.rb +478 -0
  224. data/lib/pharmaobservatory/models/investor_private_funds_row.rb +366 -0
  225. data/lib/pharmaobservatory/models/investors_record.rb +385 -0
  226. data/lib/pharmaobservatory/models/investors_response.rb +478 -0
  227. data/lib/pharmaobservatory/models/investors_row.rb +421 -0
  228. data/lib/pharmaobservatory/models/legal_entities_record.rb +2 -2
  229. data/lib/pharmaobservatory/models/legal_entities_response.rb +3 -3
  230. data/lib/pharmaobservatory/models/legal_entities_row.rb +1 -1
  231. data/lib/pharmaobservatory/models/managers_record.rb +385 -0
  232. data/lib/pharmaobservatory/models/managers_response.rb +478 -0
  233. data/lib/pharmaobservatory/models/managers_row.rb +377 -0
  234. data/lib/pharmaobservatory/models/org_disclosures_response.rb +478 -0
  235. data/lib/pharmaobservatory/models/org_disclosures_row.rb +432 -0
  236. data/lib/pharmaobservatory/models/org_relationships_response.rb +478 -0
  237. data/lib/pharmaobservatory/models/org_relationships_row.rb +498 -0
  238. data/lib/pharmaobservatory/models/ownership_positions_response.rb +3 -3
  239. data/lib/pharmaobservatory/models/ownership_positions_row.rb +26 -15
  240. data/lib/pharmaobservatory/models/pdufa_dates_response.rb +3 -3
  241. data/lib/pharmaobservatory/models/site_beds_yearly_response.rb +3 -3
  242. data/lib/pharmaobservatory/models/site_cro_trials_response.rb +3 -3
  243. data/lib/pharmaobservatory/models/site_hospitals_response.rb +3 -3
  244. data/lib/pharmaobservatory/models/site_investigators_response.rb +3 -3
  245. data/lib/pharmaobservatory/models/site_trial_conditions_response.rb +3 -3
  246. data/lib/pharmaobservatory/models/site_trial_drugs_response.rb +3 -3
  247. data/lib/pharmaobservatory/models/site_trials_response.rb +3 -3
  248. data/lib/pharmaobservatory/models/sites_record.rb +2 -2
  249. data/lib/pharmaobservatory/models/sites_response.rb +3 -3
  250. data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb +3 -3
  251. data/lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb +3 -3
  252. data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb +3 -3
  253. data/lib/pharmaobservatory/models/sponsor_trials_response.rb +3 -3
  254. data/lib/pharmaobservatory/models/sponsor_trials_row.rb +1 -1
  255. data/lib/pharmaobservatory/models/supplier_capability_esg_response.rb +478 -0
  256. data/lib/pharmaobservatory/models/supplier_capability_esg_row.rb +480 -0
  257. data/lib/pharmaobservatory/models/supplier_services_response.rb +478 -0
  258. data/lib/pharmaobservatory/models/supplier_services_row.rb +289 -0
  259. data/lib/pharmaobservatory/models/supplier_sites_response.rb +478 -0
  260. data/lib/pharmaobservatory/models/supplier_sites_row.rb +357 -0
  261. data/lib/pharmaobservatory/models/suppliers_record.rb +385 -0
  262. data/lib/pharmaobservatory/models/suppliers_response.rb +478 -0
  263. data/lib/pharmaobservatory/models/suppliers_row.rb +544 -0
  264. data/lib/pharmaobservatory/models/target_associations_response.rb +478 -0
  265. data/lib/pharmaobservatory/models/target_associations_row.rb +267 -0
  266. data/lib/pharmaobservatory/models/target_crowding_response.rb +478 -0
  267. data/lib/pharmaobservatory/models/target_crowding_row.rb +289 -0
  268. data/lib/pharmaobservatory/models/target_drugs_response.rb +478 -0
  269. data/lib/pharmaobservatory/models/target_drugs_row.rb +335 -0
  270. data/lib/pharmaobservatory/models/target_evidence_response.rb +478 -0
  271. data/lib/pharmaobservatory/models/target_evidence_row.rb +410 -0
  272. data/lib/pharmaobservatory/models/target_patent_mentions_response.rb +478 -0
  273. data/lib/pharmaobservatory/models/target_patent_mentions_row.rb +311 -0
  274. data/lib/pharmaobservatory/models/target_programs_response.rb +478 -0
  275. data/lib/pharmaobservatory/models/target_programs_row.rb +447 -0
  276. data/lib/pharmaobservatory/models/target_publications_response.rb +478 -0
  277. data/lib/pharmaobservatory/models/target_publications_row.rb +300 -0
  278. data/lib/pharmaobservatory/models/target_regulatory_precedent_response.rb +478 -0
  279. data/lib/pharmaobservatory/models/target_regulatory_precedent_row.rb +333 -0
  280. data/lib/pharmaobservatory/models/target_trials_response.rb +478 -0
  281. data/lib/pharmaobservatory/models/target_trials_row.rb +377 -0
  282. data/lib/pharmaobservatory/models/targets_record.rb +385 -0
  283. data/lib/pharmaobservatory/models/targets_response.rb +478 -0
  284. data/lib/pharmaobservatory/models/targets_row.rb +498 -0
  285. data/lib/pharmaobservatory/models/trial_adverse_events_response.rb +3 -3
  286. data/lib/pharmaobservatory/models/trial_changes_response.rb +3 -3
  287. data/lib/pharmaobservatory/models/trial_delivery_response.rb +3 -3
  288. data/lib/pharmaobservatory/models/trial_demographics_response.rb +3 -3
  289. data/lib/pharmaobservatory/models/trial_drug_classes_response.rb +478 -0
  290. data/lib/pharmaobservatory/models/trial_drug_classes_row.rb +278 -0
  291. data/lib/pharmaobservatory/models/trial_drugs_response.rb +3 -3
  292. data/lib/pharmaobservatory/models/trial_enrollment_history_response.rb +3 -3
  293. data/lib/pharmaobservatory/models/trial_enrollment_rate_response.rb +3 -3
  294. data/lib/pharmaobservatory/models/trial_extracted_endpoints_response.rb +3 -3
  295. data/lib/pharmaobservatory/models/trial_kols_response.rb +478 -0
  296. data/lib/pharmaobservatory/models/trial_kols_row.rb +302 -0
  297. data/lib/pharmaobservatory/models/trial_outcome_measures_response.rb +3 -3
  298. data/lib/pharmaobservatory/models/trial_research_payments_response.rb +478 -0
  299. data/lib/pharmaobservatory/models/trial_research_payments_row.rb +366 -0
  300. data/lib/pharmaobservatory/models/trial_site_history_response.rb +478 -0
  301. data/lib/pharmaobservatory/models/trial_site_history_row.rb +401 -0
  302. data/lib/pharmaobservatory/models/trial_sites_response.rb +3 -3
  303. data/lib/pharmaobservatory/models/trials_record.rb +2 -2
  304. data/lib/pharmaobservatory/models/trials_response.rb +3 -3
  305. data/lib/pharmaobservatory/version.rb +1 -1
  306. data/lib/pharmaobservatory.rb +71 -3
  307. metadata +144 -8
checksums.yaml CHANGED
@@ -1,7 +1,7 @@
1
1
  ---
2
2
  SHA256:
3
- metadata.gz: 6ffeec6b419dc15d5c32a280ef1469a180de04fc445f3a3e87e826d99ce4b197
4
- data.tar.gz: 35d53c85a65df008e5b13a37d219f4a4928454cdabab5862c590fb43f1e34849
3
+ metadata.gz: b82da297e53a1f5dbae57ddecb86e657a5e50c8326f395b6af2fdf2a410e67ab
4
+ data.tar.gz: d18dbfa131b5176148287daf592e588c5b90acda9a1493755711cf5057ee2715
5
5
  SHA512:
6
- metadata.gz: 964df18c43a0df959d7f0d3760e46fe4f0eb1dd7b9757ef3f43b1de864f102d9f42c1c9ebfc5c7ecb9e773f89b4c63e3119740d33003aebcf1b62ab023664832
7
- data.tar.gz: b8a4ab84755f06f307e02f6b92641bd3fbf0f5c308169585631ba2d300df790340e558a91d9c8cb1f333bd137cb4cc7bd0086c64bfaec59939687f132fe54ca5
6
+ metadata.gz: 503edb3a8c8067335e597af7a692cee88188e97860bc1893a19fbab90636a160ef5a3910ee432df4142f09befaff17187b01b99b387b0a4a1895d7267c528aa4
7
+ data.tar.gz: d2e63ebabf4728719fbc292d97d548bdd1aad6b55cffeb6677273620328ce519df4af924e9bf4ff982bdc24c83451cd7eb07abdc12abb3599813c22d23881e10
data/README.md CHANGED
@@ -39,7 +39,7 @@ Read-only REST API over the Pharma Observatory biomedical data platform. Referen
39
39
  This SDK is automatically generated by the [OpenAPI Generator](https://openapi-generator.tech) project:
40
40
 
41
41
  - API version: 1.0.0
42
- - Package version: 0.1.5
42
+ - Package version: 0.1.6
43
43
  - Generator version: 7.13.0
44
44
  - Build package: org.openapitools.codegen.languages.RubyClientCodegen
45
45
 
@@ -56,16 +56,16 @@ gem build pharmaobservatory.gemspec
56
56
  Then either install the gem locally:
57
57
 
58
58
  ```shell
59
- gem install ./pharmaobservatory-0.1.5.gem
59
+ gem install ./pharmaobservatory-0.1.6.gem
60
60
  ```
61
61
 
62
- (for development, run `gem install --dev ./pharmaobservatory-0.1.5.gem` to install the development dependencies)
62
+ (for development, run `gem install --dev ./pharmaobservatory-0.1.6.gem` to install the development dependencies)
63
63
 
64
64
  or publish the gem to a gem hosting service, e.g. [RubyGems](https://rubygems.org/).
65
65
 
66
66
  Finally add this to the Gemfile:
67
67
 
68
- gem 'pharmaobservatory', '~> 0.1.5'
68
+ gem 'pharmaobservatory', '~> 0.1.6'
69
69
 
70
70
  ### Install from Git
71
71
 
@@ -118,6 +118,8 @@ All URIs are relative to *https://pharmaobservatory.com*
118
118
  Class | Method | HTTP request | Description
119
119
  ------------ | ------------- | ------------- | -------------
120
120
  *PharmaObservatory::ApiV1BaseApi* | [**api_v1_whoami_get**](docs/ApiV1BaseApi.md#api_v1_whoami_get) | **GET** /api/v1/whoami | whoami
121
+ *PharmaObservatory::BiomarkersApi* | [**biomarkers_biomarker_assay_evidence**](docs/BiomarkersApi.md#biomarkers_biomarker_assay_evidence) | **GET** /api/v1/biomarkers/{id}/biomarker_assay_evidence | Biomarker assay evidence from the literature
122
+ *PharmaObservatory::BiomarkersApi* | [**biomarkers_biomarker_assay_whitespace**](docs/BiomarkersApi.md#biomarkers_biomarker_assay_whitespace) | **GET** /api/v1/biomarkers/{id}/biomarker_assay_whitespace | Biomarker assay whitespace (evidence against supplier supply)
121
123
  *PharmaObservatory::BiomarkersApi* | [**biomarkers_biomarker_bqp_assertions**](docs/BiomarkersApi.md#biomarkers_biomarker_bqp_assertions) | **GET** /api/v1/biomarkers/{id}/biomarker_bqp_assertions | FDA biomarker qualification projects
122
124
  *PharmaObservatory::BiomarkersApi* | [**biomarkers_biomarker_cdx_assertions**](docs/BiomarkersApi.md#biomarkers_biomarker_cdx_assertions) | **GET** /api/v1/biomarkers/{id}/biomarker_cdx_assertions | FDA companion diagnostic assertions
123
125
  *PharmaObservatory::BiomarkersApi* | [**biomarkers_biomarker_evidence**](docs/BiomarkersApi.md#biomarkers_biomarker_evidence) | **GET** /api/v1/biomarkers/{id}/biomarker_evidence | Biomarker evidence
@@ -147,12 +149,15 @@ Class | Method | HTTP request | Description
147
149
  *PharmaObservatory::CompaniesApi* | [**companies_institutional_holdings**](docs/CompaniesApi.md#companies_institutional_holdings) | **GET** /api/v1/companies/{id}/institutional_holdings | Institutional holdings (SEC Form 13F)
148
150
  *PharmaObservatory::CompaniesApi* | [**companies_legal_entities**](docs/CompaniesApi.md#companies_legal_entities) | **GET** /api/v1/companies/{id}/legal_entities | Legal entities
149
151
  *PharmaObservatory::CompaniesApi* | [**companies_list**](docs/CompaniesApi.md#companies_list) | **GET** /api/v1/companies | List companies
152
+ *PharmaObservatory::CompaniesApi* | [**companies_org_disclosures**](docs/CompaniesApi.md#companies_org_disclosures) | **GET** /api/v1/companies/{id}/org_disclosures | Organization disclosures (climate and diversity)
153
+ *PharmaObservatory::CompaniesApi* | [**companies_org_relationships**](docs/CompaniesApi.md#companies_org_relationships) | **GET** /api/v1/companies/{id}/org_relationships | Organization relationships
150
154
  *PharmaObservatory::CompaniesApi* | [**companies_ownership_positions**](docs/CompaniesApi.md#companies_ownership_positions) | **GET** /api/v1/companies/{id}/ownership_positions | Ownership and control positions
151
155
  *PharmaObservatory::CompaniesApi* | [**companies_pdufa_dates**](docs/CompaniesApi.md#companies_pdufa_dates) | **GET** /api/v1/companies/{id}/pdufa_dates | FDA decision dates (PDUFA) and catalysts
152
156
  *PharmaObservatory::CompaniesApi* | [**companies_sponsor_recruitment_by_phase**](docs/CompaniesApi.md#companies_sponsor_recruitment_by_phase) | **GET** /api/v1/companies/{id}/sponsor_recruitment_by_phase | Trial recruitment duration by sponsor and phase
153
157
  *PharmaObservatory::CompaniesApi* | [**companies_sponsor_recruitment_duration**](docs/CompaniesApi.md#companies_sponsor_recruitment_duration) | **GET** /api/v1/companies/{id}/sponsor_recruitment_duration | Trial recruitment duration by sponsor
154
158
  *PharmaObservatory::CompaniesApi* | [**companies_sponsor_trial_start_forecast**](docs/CompaniesApi.md#companies_sponsor_trial_start_forecast) | **GET** /api/v1/companies/{id}/sponsor_trial_start_forecast | Trial-start forecast by sponsor
155
159
  *PharmaObservatory::CompaniesApi* | [**companies_sponsor_trials**](docs/CompaniesApi.md#companies_sponsor_trials) | **GET** /api/v1/companies/{id}/sponsor_trials | Sponsor trials
160
+ *PharmaObservatory::CompaniesApi* | [**companies_supplier_capability_esg**](docs/CompaniesApi.md#companies_supplier_capability_esg) | **GET** /api/v1/companies/{id}/supplier_capability_esg | Supplier capability and ESG disclosure
156
161
  *PharmaObservatory::ConditionsApi* | [**conditions_company_programs**](docs/ConditionsApi.md#conditions_company_programs) | **GET** /api/v1/conditions/{id}/company_programs | Company programs
157
162
  *PharmaObservatory::ConditionsApi* | [**conditions_condition_adverse_events**](docs/ConditionsApi.md#conditions_condition_adverse_events) | **GET** /api/v1/conditions/{id}/condition_adverse_events | Condition adverse events
158
163
  *PharmaObservatory::ConditionsApi* | [**conditions_condition_burden**](docs/ConditionsApi.md#conditions_condition_burden) | **GET** /api/v1/conditions/{id}/condition_burden | Condition burden
@@ -160,25 +165,42 @@ Class | Method | HTTP request | Description
160
165
  *PharmaObservatory::ConditionsApi* | [**conditions_condition_drugs**](docs/ConditionsApi.md#conditions_condition_drugs) | **GET** /api/v1/conditions/{id}/condition_drugs | Condition drugs
161
166
  *PharmaObservatory::ConditionsApi* | [**conditions_condition_prevalence**](docs/ConditionsApi.md#conditions_condition_prevalence) | **GET** /api/v1/conditions/{id}/condition_prevalence | Condition prevalence
162
167
  *PharmaObservatory::ConditionsApi* | [**conditions_condition_publications**](docs/ConditionsApi.md#conditions_condition_publications) | **GET** /api/v1/conditions/{id}/condition_publications | Condition publications
168
+ *PharmaObservatory::ConditionsApi* | [**conditions_condition_recruitment_by_phase**](docs/ConditionsApi.md#conditions_condition_recruitment_by_phase) | **GET** /api/v1/conditions/{id}/condition_recruitment_by_phase | Trial recruitment duration by condition and phase
169
+ *PharmaObservatory::ConditionsApi* | [**conditions_condition_recruitment_duration**](docs/ConditionsApi.md#conditions_condition_recruitment_duration) | **GET** /api/v1/conditions/{id}/condition_recruitment_duration | Trial recruitment duration by condition
163
170
  *PharmaObservatory::ConditionsApi* | [**conditions_condition_sites**](docs/ConditionsApi.md#conditions_condition_sites) | **GET** /api/v1/conditions/{id}/condition_sites | Condition sites
171
+ *PharmaObservatory::ConditionsApi* | [**conditions_condition_trial_start_forecast**](docs/ConditionsApi.md#conditions_condition_trial_start_forecast) | **GET** /api/v1/conditions/{id}/condition_trial_start_forecast | Trial-start forecast by condition
164
172
  *PharmaObservatory::ConditionsApi* | [**conditions_condition_trials**](docs/ConditionsApi.md#conditions_condition_trials) | **GET** /api/v1/conditions/{id}/condition_trials | Condition trials
165
173
  *PharmaObservatory::ConditionsApi* | [**conditions_get**](docs/ConditionsApi.md#conditions_get) | **GET** /api/v1/conditions/{id} | One condition
166
174
  *PharmaObservatory::ConditionsApi* | [**conditions_list**](docs/ConditionsApi.md#conditions_list) | **GET** /api/v1/conditions | List conditions
167
175
  *PharmaObservatory::ConditionsApi* | [**conditions_pdufa_dates**](docs/ConditionsApi.md#conditions_pdufa_dates) | **GET** /api/v1/conditions/{id}/pdufa_dates | FDA decision dates (PDUFA) and catalysts
168
176
  *PharmaObservatory::DatasetsApi* | [**datasets_get**](docs/DatasetsApi.md#datasets_get) | **GET** /api/v1/datasets/{name} | Describe a dataset
169
177
  *PharmaObservatory::DatasetsApi* | [**datasets_list**](docs/DatasetsApi.md#datasets_list) | **GET** /api/v1/datasets | List the datasets
178
+ *PharmaObservatory::InvestorsApi* | [**investors_get**](docs/InvestorsApi.md#investors_get) | **GET** /api/v1/investors/{id} | One investor
179
+ *PharmaObservatory::InvestorsApi* | [**investors_institutional_holdings**](docs/InvestorsApi.md#investors_institutional_holdings) | **GET** /api/v1/investors/{id}/institutional_holdings | Institutional holdings (SEC Form 13F)
180
+ *PharmaObservatory::InvestorsApi* | [**investors_investor_funds**](docs/InvestorsApi.md#investors_investor_funds) | **GET** /api/v1/investors/{id}/investor_funds | Investor private funds by type
181
+ *PharmaObservatory::InvestorsApi* | [**investors_investor_portfolio**](docs/InvestorsApi.md#investors_investor_portfolio) | **GET** /api/v1/investors/{id}/investor_portfolio | Investor portfolio (offering filings)
182
+ *PharmaObservatory::InvestorsApi* | [**investors_investor_private_funds**](docs/InvestorsApi.md#investors_investor_private_funds) | **GET** /api/v1/investors/{id}/investor_private_funds | Investor private funds
183
+ *PharmaObservatory::InvestorsApi* | [**investors_list**](docs/InvestorsApi.md#investors_list) | **GET** /api/v1/investors | List investors
184
+ *PharmaObservatory::InvestorsApi* | [**investors_managers**](docs/InvestorsApi.md#investors_managers) | **GET** /api/v1/investors/{id}/managers | Institutional managers (SEC Form 13F)
185
+ *PharmaObservatory::InvestorsApi* | [**investors_ownership_positions**](docs/InvestorsApi.md#investors_ownership_positions) | **GET** /api/v1/investors/{id}/ownership_positions | Ownership and control positions
170
186
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_company_assets**](docs/LegalEntitiesApi.md#legal_entities_company_assets) | **GET** /api/v1/legal_entities/{id}/company_assets | Company assets (approved and marketed drugs)
171
187
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_company_programs**](docs/LegalEntitiesApi.md#legal_entities_company_programs) | **GET** /api/v1/legal_entities/{id}/company_programs | Company programs
172
188
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_drug_patent_cliff**](docs/LegalEntitiesApi.md#legal_entities_drug_patent_cliff) | **GET** /api/v1/legal_entities/{id}/drug_patent_cliff | Patent-cliff exposure
173
189
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_get**](docs/LegalEntitiesApi.md#legal_entities_get) | **GET** /api/v1/legal_entities/{id} | One legal entity
174
190
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_institutional_holdings**](docs/LegalEntitiesApi.md#legal_entities_institutional_holdings) | **GET** /api/v1/legal_entities/{id}/institutional_holdings | Institutional holdings (SEC Form 13F)
175
191
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_list**](docs/LegalEntitiesApi.md#legal_entities_list) | **GET** /api/v1/legal_entities | List legal entities
192
+ *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_org_disclosures**](docs/LegalEntitiesApi.md#legal_entities_org_disclosures) | **GET** /api/v1/legal_entities/{id}/org_disclosures | Organization disclosures (climate and diversity)
193
+ *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_org_relationships**](docs/LegalEntitiesApi.md#legal_entities_org_relationships) | **GET** /api/v1/legal_entities/{id}/org_relationships | Organization relationships
176
194
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_ownership_positions**](docs/LegalEntitiesApi.md#legal_entities_ownership_positions) | **GET** /api/v1/legal_entities/{id}/ownership_positions | Ownership and control positions
177
195
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_pdufa_dates**](docs/LegalEntitiesApi.md#legal_entities_pdufa_dates) | **GET** /api/v1/legal_entities/{id}/pdufa_dates | FDA decision dates (PDUFA) and catalysts
178
196
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_sponsor_recruitment_by_phase**](docs/LegalEntitiesApi.md#legal_entities_sponsor_recruitment_by_phase) | **GET** /api/v1/legal_entities/{id}/sponsor_recruitment_by_phase | Trial recruitment duration by sponsor and phase
179
197
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_sponsor_recruitment_duration**](docs/LegalEntitiesApi.md#legal_entities_sponsor_recruitment_duration) | **GET** /api/v1/legal_entities/{id}/sponsor_recruitment_duration | Trial recruitment duration by sponsor
180
198
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_sponsor_trial_start_forecast**](docs/LegalEntitiesApi.md#legal_entities_sponsor_trial_start_forecast) | **GET** /api/v1/legal_entities/{id}/sponsor_trial_start_forecast | Trial-start forecast by sponsor
181
199
  *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_sponsor_trials**](docs/LegalEntitiesApi.md#legal_entities_sponsor_trials) | **GET** /api/v1/legal_entities/{id}/sponsor_trials | Sponsor trials
200
+ *PharmaObservatory::LegalEntitiesApi* | [**legal_entities_supplier_capability_esg**](docs/LegalEntitiesApi.md#legal_entities_supplier_capability_esg) | **GET** /api/v1/legal_entities/{id}/supplier_capability_esg | Supplier capability and ESG disclosure
201
+ *PharmaObservatory::ManagersApi* | [**managers_get**](docs/ManagersApi.md#managers_get) | **GET** /api/v1/managers/{id} | One form 13f manager
202
+ *PharmaObservatory::ManagersApi* | [**managers_institutional_holdings**](docs/ManagersApi.md#managers_institutional_holdings) | **GET** /api/v1/managers/{id}/institutional_holdings | Institutional holdings (SEC Form 13F)
203
+ *PharmaObservatory::ManagersApi* | [**managers_list**](docs/ManagersApi.md#managers_list) | **GET** /api/v1/managers | List form 13f managers
182
204
  *PharmaObservatory::QueryApi* | [**query_result**](docs/QueryApi.md#query_result) | **GET** /api/v1/results/{result_id} | Page a stored result
183
205
  *PharmaObservatory::QueryApi* | [**query_run**](docs/QueryApi.md#query_run) | **POST** /api/v1/query | Run a SQL query
184
206
  *PharmaObservatory::SitesApi* | [**sites_get**](docs/SitesApi.md#sites_get) | **GET** /api/v1/sites/{id} | One site
@@ -190,6 +212,23 @@ Class | Method | HTTP request | Description
190
212
  *PharmaObservatory::SitesApi* | [**sites_site_trial_conditions**](docs/SitesApi.md#sites_site_trial_conditions) | **GET** /api/v1/sites/{id}/site_trial_conditions | Site trial conditions
191
213
  *PharmaObservatory::SitesApi* | [**sites_site_trial_drugs**](docs/SitesApi.md#sites_site_trial_drugs) | **GET** /api/v1/sites/{id}/site_trial_drugs | Site trial drugs
192
214
  *PharmaObservatory::SitesApi* | [**sites_site_trials**](docs/SitesApi.md#sites_site_trials) | **GET** /api/v1/sites/{id}/site_trials | Site trials
215
+ *PharmaObservatory::SuppliersApi* | [**suppliers_get**](docs/SuppliersApi.md#suppliers_get) | **GET** /api/v1/suppliers/{id} | One supplier
216
+ *PharmaObservatory::SuppliersApi* | [**suppliers_list**](docs/SuppliersApi.md#suppliers_list) | **GET** /api/v1/suppliers | List suppliers
217
+ *PharmaObservatory::SuppliersApi* | [**suppliers_supplier_services**](docs/SuppliersApi.md#suppliers_supplier_services) | **GET** /api/v1/suppliers/{id}/supplier_services | Supplier services
218
+ *PharmaObservatory::SuppliersApi* | [**suppliers_supplier_sites**](docs/SuppliersApi.md#suppliers_supplier_sites) | **GET** /api/v1/suppliers/{id}/supplier_sites | Supplier sites
219
+ *PharmaObservatory::TargetsApi* | [**targets_biomarker_evidence**](docs/TargetsApi.md#targets_biomarker_evidence) | **GET** /api/v1/targets/{id}/biomarker_evidence | Biomarker evidence
220
+ *PharmaObservatory::TargetsApi* | [**targets_company_targets**](docs/TargetsApi.md#targets_company_targets) | **GET** /api/v1/targets/{id}/company_targets | Targets a company pursues
221
+ *PharmaObservatory::TargetsApi* | [**targets_get**](docs/TargetsApi.md#targets_get) | **GET** /api/v1/targets/{id} | One target
222
+ *PharmaObservatory::TargetsApi* | [**targets_list**](docs/TargetsApi.md#targets_list) | **GET** /api/v1/targets | List targets
223
+ *PharmaObservatory::TargetsApi* | [**targets_target_associations**](docs/TargetsApi.md#targets_target_associations) | **GET** /api/v1/targets/{id}/target_associations | Target-disease associations by datasource
224
+ *PharmaObservatory::TargetsApi* | [**targets_target_crowding**](docs/TargetsApi.md#targets_target_crowding) | **GET** /api/v1/targets/{id}/target_crowding | Target crowding by phase
225
+ *PharmaObservatory::TargetsApi* | [**targets_target_drugs**](docs/TargetsApi.md#targets_target_drugs) | **GET** /api/v1/targets/{id}/target_drugs | Drugs acting on a target
226
+ *PharmaObservatory::TargetsApi* | [**targets_target_evidence**](docs/TargetsApi.md#targets_target_evidence) | **GET** /api/v1/targets/{id}/target_evidence | Target evidence
227
+ *PharmaObservatory::TargetsApi* | [**targets_target_patent_mentions**](docs/TargetsApi.md#targets_target_patent_mentions) | **GET** /api/v1/targets/{id}/target_patent_mentions | Target patent mentions
228
+ *PharmaObservatory::TargetsApi* | [**targets_target_programs**](docs/TargetsApi.md#targets_target_programs) | **GET** /api/v1/targets/{id}/target_programs | Target development programs
229
+ *PharmaObservatory::TargetsApi* | [**targets_target_publications**](docs/TargetsApi.md#targets_target_publications) | **GET** /api/v1/targets/{id}/target_publications | Target publications
230
+ *PharmaObservatory::TargetsApi* | [**targets_target_regulatory_precedent**](docs/TargetsApi.md#targets_target_regulatory_precedent) | **GET** /api/v1/targets/{id}/target_regulatory_precedent | Target regulatory precedent
231
+ *PharmaObservatory::TargetsApi* | [**targets_target_trials**](docs/TargetsApi.md#targets_target_trials) | **GET** /api/v1/targets/{id}/target_trials | Trials targeting a target
193
232
  *PharmaObservatory::TrialsApi* | [**trials_get**](docs/TrialsApi.md#trials_get) | **GET** /api/v1/trials/{id} | One trial
194
233
  *PharmaObservatory::TrialsApi* | [**trials_list**](docs/TrialsApi.md#trials_list) | **GET** /api/v1/trials | List trials
195
234
  *PharmaObservatory::TrialsApi* | [**trials_sponsor_trials**](docs/TrialsApi.md#trials_sponsor_trials) | **GET** /api/v1/trials/{id}/sponsor_trials | Sponsor trials
@@ -197,11 +236,15 @@ Class | Method | HTTP request | Description
197
236
  *PharmaObservatory::TrialsApi* | [**trials_trial_changes**](docs/TrialsApi.md#trials_trial_changes) | **GET** /api/v1/trials/{id}/trial_changes | Trial changes
198
237
  *PharmaObservatory::TrialsApi* | [**trials_trial_delivery**](docs/TrialsApi.md#trials_trial_delivery) | **GET** /api/v1/trials/{id}/trial_delivery | Trial delivery
199
238
  *PharmaObservatory::TrialsApi* | [**trials_trial_demographics**](docs/TrialsApi.md#trials_trial_demographics) | **GET** /api/v1/trials/{id}/trial_demographics | Trial demographics
239
+ *PharmaObservatory::TrialsApi* | [**trials_trial_drug_classes**](docs/TrialsApi.md#trials_trial_drug_classes) | **GET** /api/v1/trials/{id}/trial_drug_classes | Trial drug classes
200
240
  *PharmaObservatory::TrialsApi* | [**trials_trial_drugs**](docs/TrialsApi.md#trials_trial_drugs) | **GET** /api/v1/trials/{id}/trial_drugs | Trial drugs
201
241
  *PharmaObservatory::TrialsApi* | [**trials_trial_enrollment_history**](docs/TrialsApi.md#trials_trial_enrollment_history) | **GET** /api/v1/trials/{id}/trial_enrollment_history | Trial enrollment history
202
242
  *PharmaObservatory::TrialsApi* | [**trials_trial_enrollment_rate**](docs/TrialsApi.md#trials_trial_enrollment_rate) | **GET** /api/v1/trials/{id}/trial_enrollment_rate | Trial enrollment rate
203
243
  *PharmaObservatory::TrialsApi* | [**trials_trial_extracted_endpoints**](docs/TrialsApi.md#trials_trial_extracted_endpoints) | **GET** /api/v1/trials/{id}/trial_extracted_endpoints | Trial extracted endpoints
244
+ *PharmaObservatory::TrialsApi* | [**trials_trial_kols**](docs/TrialsApi.md#trials_trial_kols) | **GET** /api/v1/trials/{id}/trial_kols | Trial investigators
204
245
  *PharmaObservatory::TrialsApi* | [**trials_trial_outcome_measures**](docs/TrialsApi.md#trials_trial_outcome_measures) | **GET** /api/v1/trials/{id}/trial_outcome_measures | Trial outcome measures
246
+ *PharmaObservatory::TrialsApi* | [**trials_trial_research_payments**](docs/TrialsApi.md#trials_trial_research_payments) | **GET** /api/v1/trials/{id}/trial_research_payments | Trial research payments
247
+ *PharmaObservatory::TrialsApi* | [**trials_trial_site_history**](docs/TrialsApi.md#trials_trial_site_history) | **GET** /api/v1/trials/{id}/trial_site_history | Trial site history
205
248
  *PharmaObservatory::TrialsApi* | [**trials_trial_sites**](docs/TrialsApi.md#trials_trial_sites) | **GET** /api/v1/trials/{id}/trial_sites | Trial sites
206
249
 
207
250
 
@@ -213,12 +256,16 @@ Class | Method | HTTP request | Description
213
256
  - [PharmaObservatory::ApiV1WhoamiGet200ResponseQuotaBuckets](docs/ApiV1WhoamiGet200ResponseQuotaBuckets.md)
214
257
  - [PharmaObservatory::ApiV1WhoamiGet200ResponseQuotaBucketsRequestsPerMinute](docs/ApiV1WhoamiGet200ResponseQuotaBucketsRequestsPerMinute.md)
215
258
  - [PharmaObservatory::AuthError](docs/AuthError.md)
259
+ - [PharmaObservatory::BiomarkerAssayEvidenceResponse](docs/BiomarkerAssayEvidenceResponse.md)
260
+ - [PharmaObservatory::BiomarkerAssayEvidenceResponseBuild](docs/BiomarkerAssayEvidenceResponseBuild.md)
261
+ - [PharmaObservatory::BiomarkerAssayEvidenceResponseFreshness](docs/BiomarkerAssayEvidenceResponseFreshness.md)
262
+ - [PharmaObservatory::BiomarkerAssayEvidenceResponseScope](docs/BiomarkerAssayEvidenceResponseScope.md)
263
+ - [PharmaObservatory::BiomarkerAssayEvidenceRow](docs/BiomarkerAssayEvidenceRow.md)
264
+ - [PharmaObservatory::BiomarkerAssayWhitespaceResponse](docs/BiomarkerAssayWhitespaceResponse.md)
265
+ - [PharmaObservatory::BiomarkerAssayWhitespaceRow](docs/BiomarkerAssayWhitespaceRow.md)
216
266
  - [PharmaObservatory::BiomarkerBqpAssertionsResponse](docs/BiomarkerBqpAssertionsResponse.md)
217
267
  - [PharmaObservatory::BiomarkerBqpAssertionsRow](docs/BiomarkerBqpAssertionsRow.md)
218
268
  - [PharmaObservatory::BiomarkerCdxAssertionsResponse](docs/BiomarkerCdxAssertionsResponse.md)
219
- - [PharmaObservatory::BiomarkerCdxAssertionsResponseBuild](docs/BiomarkerCdxAssertionsResponseBuild.md)
220
- - [PharmaObservatory::BiomarkerCdxAssertionsResponseFreshness](docs/BiomarkerCdxAssertionsResponseFreshness.md)
221
- - [PharmaObservatory::BiomarkerCdxAssertionsResponseScope](docs/BiomarkerCdxAssertionsResponseScope.md)
222
269
  - [PharmaObservatory::BiomarkerCdxAssertionsRow](docs/BiomarkerCdxAssertionsRow.md)
223
270
  - [PharmaObservatory::BiomarkerEvidenceResponse](docs/BiomarkerEvidenceResponse.md)
224
271
  - [PharmaObservatory::BiomarkerEvidenceRow](docs/BiomarkerEvidenceRow.md)
@@ -270,8 +317,14 @@ Class | Method | HTTP request | Description
270
317
  - [PharmaObservatory::ConditionPrevalenceRow](docs/ConditionPrevalenceRow.md)
271
318
  - [PharmaObservatory::ConditionPublicationsResponse](docs/ConditionPublicationsResponse.md)
272
319
  - [PharmaObservatory::ConditionPublicationsRow](docs/ConditionPublicationsRow.md)
320
+ - [PharmaObservatory::ConditionRecruitmentByPhaseResponse](docs/ConditionRecruitmentByPhaseResponse.md)
321
+ - [PharmaObservatory::ConditionRecruitmentByPhaseRow](docs/ConditionRecruitmentByPhaseRow.md)
322
+ - [PharmaObservatory::ConditionRecruitmentDurationResponse](docs/ConditionRecruitmentDurationResponse.md)
323
+ - [PharmaObservatory::ConditionRecruitmentDurationRow](docs/ConditionRecruitmentDurationRow.md)
273
324
  - [PharmaObservatory::ConditionSitesResponse](docs/ConditionSitesResponse.md)
274
325
  - [PharmaObservatory::ConditionSitesRow](docs/ConditionSitesRow.md)
326
+ - [PharmaObservatory::ConditionTrialStartForecastResponse](docs/ConditionTrialStartForecastResponse.md)
327
+ - [PharmaObservatory::ConditionTrialStartForecastRow](docs/ConditionTrialStartForecastRow.md)
275
328
  - [PharmaObservatory::ConditionTrialsResponse](docs/ConditionTrialsResponse.md)
276
329
  - [PharmaObservatory::ConditionTrialsRow](docs/ConditionTrialsRow.md)
277
330
  - [PharmaObservatory::ConditionsRecord](docs/ConditionsRecord.md)
@@ -288,10 +341,26 @@ Class | Method | HTTP request | Description
288
341
  - [PharmaObservatory::DrugPatentCliffRow](docs/DrugPatentCliffRow.md)
289
342
  - [PharmaObservatory::InstitutionalHoldingsResponse](docs/InstitutionalHoldingsResponse.md)
290
343
  - [PharmaObservatory::InstitutionalHoldingsRow](docs/InstitutionalHoldingsRow.md)
344
+ - [PharmaObservatory::InvestorFundsResponse](docs/InvestorFundsResponse.md)
345
+ - [PharmaObservatory::InvestorFundsRow](docs/InvestorFundsRow.md)
346
+ - [PharmaObservatory::InvestorPortfolioResponse](docs/InvestorPortfolioResponse.md)
347
+ - [PharmaObservatory::InvestorPortfolioRow](docs/InvestorPortfolioRow.md)
348
+ - [PharmaObservatory::InvestorPrivateFundsResponse](docs/InvestorPrivateFundsResponse.md)
349
+ - [PharmaObservatory::InvestorPrivateFundsRow](docs/InvestorPrivateFundsRow.md)
350
+ - [PharmaObservatory::InvestorsRecord](docs/InvestorsRecord.md)
351
+ - [PharmaObservatory::InvestorsResponse](docs/InvestorsResponse.md)
352
+ - [PharmaObservatory::InvestorsRow](docs/InvestorsRow.md)
291
353
  - [PharmaObservatory::LegalEntitiesRecord](docs/LegalEntitiesRecord.md)
292
354
  - [PharmaObservatory::LegalEntitiesRecordAttributes](docs/LegalEntitiesRecordAttributes.md)
293
355
  - [PharmaObservatory::LegalEntitiesResponse](docs/LegalEntitiesResponse.md)
294
356
  - [PharmaObservatory::LegalEntitiesRow](docs/LegalEntitiesRow.md)
357
+ - [PharmaObservatory::ManagersRecord](docs/ManagersRecord.md)
358
+ - [PharmaObservatory::ManagersResponse](docs/ManagersResponse.md)
359
+ - [PharmaObservatory::ManagersRow](docs/ManagersRow.md)
360
+ - [PharmaObservatory::OrgDisclosuresResponse](docs/OrgDisclosuresResponse.md)
361
+ - [PharmaObservatory::OrgDisclosuresRow](docs/OrgDisclosuresRow.md)
362
+ - [PharmaObservatory::OrgRelationshipsResponse](docs/OrgRelationshipsResponse.md)
363
+ - [PharmaObservatory::OrgRelationshipsRow](docs/OrgRelationshipsRow.md)
295
364
  - [PharmaObservatory::OwnershipPositionsResponse](docs/OwnershipPositionsResponse.md)
296
365
  - [PharmaObservatory::OwnershipPositionsRow](docs/OwnershipPositionsRow.md)
297
366
  - [PharmaObservatory::PdufaDatesResponse](docs/PdufaDatesResponse.md)
@@ -327,6 +396,36 @@ Class | Method | HTTP request | Description
327
396
  - [PharmaObservatory::SponsorTrialStartForecastRow](docs/SponsorTrialStartForecastRow.md)
328
397
  - [PharmaObservatory::SponsorTrialsResponse](docs/SponsorTrialsResponse.md)
329
398
  - [PharmaObservatory::SponsorTrialsRow](docs/SponsorTrialsRow.md)
399
+ - [PharmaObservatory::SupplierCapabilityEsgResponse](docs/SupplierCapabilityEsgResponse.md)
400
+ - [PharmaObservatory::SupplierCapabilityEsgRow](docs/SupplierCapabilityEsgRow.md)
401
+ - [PharmaObservatory::SupplierServicesResponse](docs/SupplierServicesResponse.md)
402
+ - [PharmaObservatory::SupplierServicesRow](docs/SupplierServicesRow.md)
403
+ - [PharmaObservatory::SupplierSitesResponse](docs/SupplierSitesResponse.md)
404
+ - [PharmaObservatory::SupplierSitesRow](docs/SupplierSitesRow.md)
405
+ - [PharmaObservatory::SuppliersRecord](docs/SuppliersRecord.md)
406
+ - [PharmaObservatory::SuppliersResponse](docs/SuppliersResponse.md)
407
+ - [PharmaObservatory::SuppliersRow](docs/SuppliersRow.md)
408
+ - [PharmaObservatory::TargetAssociationsResponse](docs/TargetAssociationsResponse.md)
409
+ - [PharmaObservatory::TargetAssociationsRow](docs/TargetAssociationsRow.md)
410
+ - [PharmaObservatory::TargetCrowdingResponse](docs/TargetCrowdingResponse.md)
411
+ - [PharmaObservatory::TargetCrowdingRow](docs/TargetCrowdingRow.md)
412
+ - [PharmaObservatory::TargetDrugsResponse](docs/TargetDrugsResponse.md)
413
+ - [PharmaObservatory::TargetDrugsRow](docs/TargetDrugsRow.md)
414
+ - [PharmaObservatory::TargetEvidenceResponse](docs/TargetEvidenceResponse.md)
415
+ - [PharmaObservatory::TargetEvidenceRow](docs/TargetEvidenceRow.md)
416
+ - [PharmaObservatory::TargetPatentMentionsResponse](docs/TargetPatentMentionsResponse.md)
417
+ - [PharmaObservatory::TargetPatentMentionsRow](docs/TargetPatentMentionsRow.md)
418
+ - [PharmaObservatory::TargetProgramsResponse](docs/TargetProgramsResponse.md)
419
+ - [PharmaObservatory::TargetProgramsRow](docs/TargetProgramsRow.md)
420
+ - [PharmaObservatory::TargetPublicationsResponse](docs/TargetPublicationsResponse.md)
421
+ - [PharmaObservatory::TargetPublicationsRow](docs/TargetPublicationsRow.md)
422
+ - [PharmaObservatory::TargetRegulatoryPrecedentResponse](docs/TargetRegulatoryPrecedentResponse.md)
423
+ - [PharmaObservatory::TargetRegulatoryPrecedentRow](docs/TargetRegulatoryPrecedentRow.md)
424
+ - [PharmaObservatory::TargetTrialsResponse](docs/TargetTrialsResponse.md)
425
+ - [PharmaObservatory::TargetTrialsRow](docs/TargetTrialsRow.md)
426
+ - [PharmaObservatory::TargetsRecord](docs/TargetsRecord.md)
427
+ - [PharmaObservatory::TargetsResponse](docs/TargetsResponse.md)
428
+ - [PharmaObservatory::TargetsRow](docs/TargetsRow.md)
330
429
  - [PharmaObservatory::TrialAdverseEventsResponse](docs/TrialAdverseEventsResponse.md)
331
430
  - [PharmaObservatory::TrialAdverseEventsRow](docs/TrialAdverseEventsRow.md)
332
431
  - [PharmaObservatory::TrialChangesResponse](docs/TrialChangesResponse.md)
@@ -335,6 +434,8 @@ Class | Method | HTTP request | Description
335
434
  - [PharmaObservatory::TrialDeliveryRow](docs/TrialDeliveryRow.md)
336
435
  - [PharmaObservatory::TrialDemographicsResponse](docs/TrialDemographicsResponse.md)
337
436
  - [PharmaObservatory::TrialDemographicsRow](docs/TrialDemographicsRow.md)
437
+ - [PharmaObservatory::TrialDrugClassesResponse](docs/TrialDrugClassesResponse.md)
438
+ - [PharmaObservatory::TrialDrugClassesRow](docs/TrialDrugClassesRow.md)
338
439
  - [PharmaObservatory::TrialDrugsResponse](docs/TrialDrugsResponse.md)
339
440
  - [PharmaObservatory::TrialDrugsRow](docs/TrialDrugsRow.md)
340
441
  - [PharmaObservatory::TrialEnrollmentHistoryResponse](docs/TrialEnrollmentHistoryResponse.md)
@@ -343,8 +444,14 @@ Class | Method | HTTP request | Description
343
444
  - [PharmaObservatory::TrialEnrollmentRateRow](docs/TrialEnrollmentRateRow.md)
344
445
  - [PharmaObservatory::TrialExtractedEndpointsResponse](docs/TrialExtractedEndpointsResponse.md)
345
446
  - [PharmaObservatory::TrialExtractedEndpointsRow](docs/TrialExtractedEndpointsRow.md)
447
+ - [PharmaObservatory::TrialKolsResponse](docs/TrialKolsResponse.md)
448
+ - [PharmaObservatory::TrialKolsRow](docs/TrialKolsRow.md)
346
449
  - [PharmaObservatory::TrialOutcomeMeasuresResponse](docs/TrialOutcomeMeasuresResponse.md)
347
450
  - [PharmaObservatory::TrialOutcomeMeasuresRow](docs/TrialOutcomeMeasuresRow.md)
451
+ - [PharmaObservatory::TrialResearchPaymentsResponse](docs/TrialResearchPaymentsResponse.md)
452
+ - [PharmaObservatory::TrialResearchPaymentsRow](docs/TrialResearchPaymentsRow.md)
453
+ - [PharmaObservatory::TrialSiteHistoryResponse](docs/TrialSiteHistoryResponse.md)
454
+ - [PharmaObservatory::TrialSiteHistoryRow](docs/TrialSiteHistoryRow.md)
348
455
  - [PharmaObservatory::TrialSitesResponse](docs/TrialSitesResponse.md)
349
456
  - [PharmaObservatory::TrialSitesRow](docs/TrialSitesRow.md)
350
457
  - [PharmaObservatory::TrialsRecord](docs/TrialsRecord.md)
@@ -0,0 +1,58 @@
1
+ # PharmaObservatory::BiomarkerAssayEvidenceResponse
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **dataset** | **String** | | |
8
+ | **grain** | **String** | | [optional] |
9
+ | **object_type** | **String** | | [optional] |
10
+ | **id** | **String** | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
+ | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
+ | **rows** | [**Array<BiomarkerAssayEvidenceRow>**](BiomarkerAssayEvidenceRow.md) | | |
14
+ | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
15
+ | **next_cursor** | **String** | | [optional] |
16
+ | **sort** | **Array<String>** | | [optional] |
17
+ | **filters** | **Array<Hash<String, Object>>** | | [optional] |
18
+ | **group_by** | **Array<String>** | | [optional] |
19
+ | **measures** | **Array<String>** | | [optional] |
20
+ | **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
21
+ | **source_credit** | **String** | | [optional] |
22
+ | **withheld_tiers** | **Array<String>** | | [optional] |
23
+ | **withheld_columns** | **Array<String>** | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
+ | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
+ | **restriction** | **Hash<String, Object>** | | [optional] |
28
+
29
+ ## Example
30
+
31
+ ```ruby
32
+ require 'pharmaobservatory'
33
+
34
+ instance = PharmaObservatory::BiomarkerAssayEvidenceResponse.new(
35
+ dataset: null,
36
+ grain: null,
37
+ object_type: null,
38
+ id: null,
39
+ scope: null,
40
+ columns: null,
41
+ rows: null,
42
+ total: null,
43
+ next_cursor: null,
44
+ sort: null,
45
+ filters: null,
46
+ group_by: null,
47
+ measures: null,
48
+ attribution: null,
49
+ source_credit: null,
50
+ withheld_tiers: null,
51
+ withheld_columns: null,
52
+ freshness: null,
53
+ build: null,
54
+ build_state: null,
55
+ restriction: null
56
+ )
57
+ ```
58
+
@@ -1,4 +1,4 @@
1
- # PharmaObservatory::BiomarkerCdxAssertionsResponseBuild
1
+ # PharmaObservatory::BiomarkerAssayEvidenceResponseBuild
2
2
 
3
3
  ## Properties
4
4
 
@@ -12,7 +12,7 @@
12
12
  ```ruby
13
13
  require 'pharmaobservatory'
14
14
 
15
- instance = PharmaObservatory::BiomarkerCdxAssertionsResponseBuild.new(
15
+ instance = PharmaObservatory::BiomarkerAssayEvidenceResponseBuild.new(
16
16
  generation: null,
17
17
  fingerprint: null
18
18
  )
@@ -1,4 +1,4 @@
1
- # PharmaObservatory::BiomarkerCdxAssertionsResponseFreshness
1
+ # PharmaObservatory::BiomarkerAssayEvidenceResponseFreshness
2
2
 
3
3
  ## Properties
4
4
 
@@ -12,7 +12,7 @@
12
12
  ```ruby
13
13
  require 'pharmaobservatory'
14
14
 
15
- instance = PharmaObservatory::BiomarkerCdxAssertionsResponseFreshness.new(
15
+ instance = PharmaObservatory::BiomarkerAssayEvidenceResponseFreshness.new(
16
16
  source: null,
17
17
  last_loaded: null
18
18
  )
@@ -1,4 +1,4 @@
1
- # PharmaObservatory::BiomarkerCdxAssertionsResponseScope
1
+ # PharmaObservatory::BiomarkerAssayEvidenceResponseScope
2
2
 
3
3
  ## Properties
4
4
 
@@ -13,7 +13,7 @@
13
13
  ```ruby
14
14
  require 'pharmaobservatory'
15
15
 
16
- instance = PharmaObservatory::BiomarkerCdxAssertionsResponseScope.new(
16
+ instance = PharmaObservatory::BiomarkerAssayEvidenceResponseScope.new(
17
17
  kind: null,
18
18
  group_id: null,
19
19
  group_name: null
@@ -0,0 +1,68 @@
1
+ # PharmaObservatory::BiomarkerAssayEvidenceRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **biomarker_assay_evidence_id** | **String** | The extracted mention's id. | [optional] |
8
+ | **route_key** | **String** | The route key of the gene the mention resolved to, the entry key for the biomarkers object type. Null when the gene did not resolve. | [optional] |
9
+ | **biomarker_id** | **String** | The resolved gene's biomarker key. Null when the gene did not resolve. | [optional] |
10
+ | **document_id** | **String** | The id of the source document the facts were extracted from. | [optional] |
11
+ | **pmid** | **String** | The PubMed id of the paper. | [optional] |
12
+ | **biomarker_ordinal** | **Integer** | The position of the mention in the paper's extracted biomarker list, from 1. | [optional] |
13
+ | **biomarker_name_as_extracted** | **String** | The biomarker name as extracted. | [optional] |
14
+ | **gene_symbol_as_extracted** | **String** | The gene symbol as extracted, before resolution. Null when the mention names no gene. | [optional] |
15
+ | **biomarker_synonyms** | **Array<String>** | The synonyms the paper gives, a document-level list repeated on each of its rows. | [optional] |
16
+ | **gene_resolution_status** | **String** | How the mention resolved to a gene. resolved_direct: exact symbol match. resolved_alias: an unambiguous dictionary alias. unresolved: a symbol was extracted that matches nothing or an ambiguous alias; not guessed. not_applicable: no gene symbol was extracted. | [optional] |
17
+ | **gene_resolution_method** | **String** | exact_gene_symbol or dictionary_alias; null when the gene did not resolve. | [optional] |
18
+ | **assay_name** | **String** | The assay, trade name or platform the paper names. A document-level value. | [optional] |
19
+ | **specimen_type** | **String** | The specimen type (blood, plasma, tissue). A document-level value. | [optional] |
20
+ | **comparator_method** | **String** | The reference method the performance was measured against, when reported. | [optional] |
21
+ | **reported_performance** | **String** | The performance as the paper states it (sensitivity, specificity, area under the curve), as text and not computed. | [optional] |
22
+ | **validation_type_mentioned** | **String** | What the paper claims about the validation type: a fact about the text, not a tier. | [optional] |
23
+ | **assay_provider_company** | **Array<String>** | Organization names as extracted that run or provide the assay. Not resolved to a company. | [optional] |
24
+ | **funding_organizations** | **Array<String>** | Organization names as extracted that funded the study. Never merged with the assay provider. | [optional] |
25
+ | **evidence_type** | **String** | Always literature_assay_validation, which tells these rows from the other evidence types. | [optional] |
26
+ | **evidence_quote** | **Array<String>** | The sentences of the paper the facts were read from. Null when the extraction gave none. | [optional] |
27
+ | **confidence** | **String** | The extraction model's self-reported confidence. Not a reliability signal: it does not track whether the extraction is correct; never use it as a quality gate. | [optional] |
28
+ | **title** | **String** | The paper's title. | [optional] |
29
+ | **published_at** | **Time** | The paper's publication timestamp, in UTC. Null for about one paper in seven, whose source gives a bare year. | [optional] |
30
+ | **extraction_model** | **String** | The model that extracted the facts. | [optional] |
31
+ | **extracted_at** | **Time** | When the facts were extracted, in UTC. | [optional] |
32
+ | **source_url** | **String** | The address of the paper the facts were extracted from. | [optional] |
33
+
34
+ ## Example
35
+
36
+ ```ruby
37
+ require 'pharmaobservatory'
38
+
39
+ instance = PharmaObservatory::BiomarkerAssayEvidenceRow.new(
40
+ biomarker_assay_evidence_id: null,
41
+ route_key: null,
42
+ biomarker_id: null,
43
+ document_id: null,
44
+ pmid: null,
45
+ biomarker_ordinal: null,
46
+ biomarker_name_as_extracted: null,
47
+ gene_symbol_as_extracted: null,
48
+ biomarker_synonyms: null,
49
+ gene_resolution_status: null,
50
+ gene_resolution_method: null,
51
+ assay_name: null,
52
+ specimen_type: null,
53
+ comparator_method: null,
54
+ reported_performance: null,
55
+ validation_type_mentioned: null,
56
+ assay_provider_company: null,
57
+ funding_organizations: null,
58
+ evidence_type: null,
59
+ evidence_quote: null,
60
+ confidence: null,
61
+ title: null,
62
+ published_at: null,
63
+ extraction_model: null,
64
+ extracted_at: null,
65
+ source_url: null
66
+ )
67
+ ```
68
+
@@ -0,0 +1,58 @@
1
+ # PharmaObservatory::BiomarkerAssayWhitespaceResponse
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **dataset** | **String** | | |
8
+ | **grain** | **String** | | [optional] |
9
+ | **object_type** | **String** | | [optional] |
10
+ | **id** | **String** | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
+ | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
+ | **rows** | [**Array<BiomarkerAssayWhitespaceRow>**](BiomarkerAssayWhitespaceRow.md) | | |
14
+ | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
15
+ | **next_cursor** | **String** | | [optional] |
16
+ | **sort** | **Array<String>** | | [optional] |
17
+ | **filters** | **Array<Hash<String, Object>>** | | [optional] |
18
+ | **group_by** | **Array<String>** | | [optional] |
19
+ | **measures** | **Array<String>** | | [optional] |
20
+ | **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
21
+ | **source_credit** | **String** | | [optional] |
22
+ | **withheld_tiers** | **Array<String>** | | [optional] |
23
+ | **withheld_columns** | **Array<String>** | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
+ | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
+ | **restriction** | **Hash<String, Object>** | | [optional] |
28
+
29
+ ## Example
30
+
31
+ ```ruby
32
+ require 'pharmaobservatory'
33
+
34
+ instance = PharmaObservatory::BiomarkerAssayWhitespaceResponse.new(
35
+ dataset: null,
36
+ grain: null,
37
+ object_type: null,
38
+ id: null,
39
+ scope: null,
40
+ columns: null,
41
+ rows: null,
42
+ total: null,
43
+ next_cursor: null,
44
+ sort: null,
45
+ filters: null,
46
+ group_by: null,
47
+ measures: null,
48
+ attribution: null,
49
+ source_credit: null,
50
+ withheld_tiers: null,
51
+ withheld_columns: null,
52
+ freshness: null,
53
+ build: null,
54
+ build_state: null,
55
+ restriction: null
56
+ )
57
+ ```
58
+
@@ -0,0 +1,66 @@
1
+ # PharmaObservatory::BiomarkerAssayWhitespaceRow
2
+
3
+ ## Properties
4
+
5
+ | Name | Type | Description | Notes |
6
+ | ---- | ---- | ----------- | ----- |
7
+ | **biomarker_id** | **String** | The gene's biomarker key. | [optional] |
8
+ | **route_key** | **String** | The gene's route key, the entry key for the biomarkers object type; the gene symbol. | [optional] |
9
+ | **gene_symbol** | **String** | The gene symbol. | [optional] |
10
+ | **biomarker_display_name** | **String** | The gene's display name. | [optional] |
11
+ | **biomarker_identity_status** | **String** | Whether the gene's identity is confirmed. | [optional] |
12
+ | **target_id** | **String** | The target's Ensembl gene id; null when the gene does not resolve one, in which case the pipeline columns are null. | [optional] |
13
+ | **whitespace_bucket** | **String** | The classification, one of nine values crossing gene_evidence_tier with gene_supply_status. Labels: no_evidence_no_supply 'No evidence, explicit no-assay'; no_evidence_supply_ambiguous 'No evidence, ambiguous supply'; supply_no_evidence 'Supply declared, no evidence'; literature_evidence_no_supply 'Literature evidence, no confirmed supply'; literature_evidence_supply_ambiguous 'Literature evidence, ambiguous supply'; literature_evidence_served 'Literature evidence, supply declared'; validated_evidence_no_supply 'Validated-ladder evidence, no confirmed supply'; validated_evidence_supply_ambiguous 'Validated-ladder evidence, ambiguous supply'; served 'Validated-ladder evidence, supply declared'. | [optional] |
14
+ | **whitespace_bucket_rule_id** | **String** | The rule that assigned the bucket, one rule per bucket. | [optional] |
15
+ | **gene_evidence_tier** | **String** | Evidence axis, a precedence and not a score. validated: at least one row of the validation ladder (biomarker_validation) for the gene. literature_only: no validated row but at least one extracted PubMed assay fact. none: neither. | [optional] |
16
+ | **gene_supply_status** | **String** | Supply axis, a precedence. declared_positive: a supplier declares an assay (validated or not). declared_ambiguous: a response conflicts or gives detail with no option chosen. declared_no_assay: a supplier answered that it has no assay. not_on_survey: no answer at all. | [optional] |
17
+ | **validated_evidence_row_count** | **Integer** | Rows of the validation ladder for the gene (biomarker_validation). A count, not a score, and not combined with the literature count. | [optional] |
18
+ | **literature_evidence_row_count** | **Integer** | Extracted PubMed assay facts resolved to the gene (biomarker_assay_evidence). A count, not a score. | [optional] |
19
+ | **evidence_types_present** | **Array<String>** | The sorted set of evidence types behind the gene's evidence, including literature_assay_validation when literature evidence exists. A set, never a rank. | [optional] |
20
+ | **evidence_tier_rule_ids_present** | **Array<String>** | The sorted set of validation ladder rule ids behind the validated evidence. For display; do not derive a rank from it. | [optional] |
21
+ | **evidence_validation_ids** | **Array<String>** | biomarker_validation_id values of the validated evidence. Empty when gene_evidence_tier is not validated. | [optional] |
22
+ | **literature_evidence_ids** | **Array<String>** | biomarker_assay_evidence_id values of the extracted PubMed facts. Populated whichever evidence tier governs the bucket. | [optional] |
23
+ | **literature_evidence_document_ids** | **Array<String>** | The source document ids behind literature_evidence_ids. | [optional] |
24
+ | **supplier_declaration_ids** | **Array<String>** | Ids of the supplier survey declarations behind gene_supply_status (the winning precedence tier). Empty when not_on_survey. The declarations are not a published dataset. | [optional] |
25
+ | **supplier_positive_response_count** | **Integer** | Supplier declarations that an assay exists, validated or unvalidated, for the gene. | [optional] |
26
+ | **supplier_conflicting_response_count** | **Integer** | Declarations whose own cells disagree. | [optional] |
27
+ | **supplier_detail_only_response_count** | **Integer** | Declarations that give free text and no selected option. | [optional] |
28
+ | **supplier_no_assay_response_count** | **Integer** | Declarations that the supplier has no assay for the gene. | [optional] |
29
+ | **pipeline_program_count** | **Integer** | Drug programs against the gene's target across every phase band. Null means the gene has no target row, never zero activity. Heat only; not part of the bucket. | [optional] |
30
+ | **pipeline_active_program_count** | **Integer** | Active drug programs against the gene's target. Same nullability as pipeline_program_count. | [optional] |
31
+ | **pipeline_max_phase** | **Integer** | The highest phase band (0 to 4) any program against the target reached; the app maps it to a phase label. Null as pipeline_program_count. | [optional] |
32
+
33
+ ## Example
34
+
35
+ ```ruby
36
+ require 'pharmaobservatory'
37
+
38
+ instance = PharmaObservatory::BiomarkerAssayWhitespaceRow.new(
39
+ biomarker_id: null,
40
+ route_key: null,
41
+ gene_symbol: null,
42
+ biomarker_display_name: null,
43
+ biomarker_identity_status: null,
44
+ target_id: null,
45
+ whitespace_bucket: null,
46
+ whitespace_bucket_rule_id: null,
47
+ gene_evidence_tier: null,
48
+ gene_supply_status: null,
49
+ validated_evidence_row_count: null,
50
+ literature_evidence_row_count: null,
51
+ evidence_types_present: null,
52
+ evidence_tier_rule_ids_present: null,
53
+ evidence_validation_ids: null,
54
+ literature_evidence_ids: null,
55
+ literature_evidence_document_ids: null,
56
+ supplier_declaration_ids: null,
57
+ supplier_positive_response_count: null,
58
+ supplier_conflicting_response_count: null,
59
+ supplier_detail_only_response_count: null,
60
+ supplier_no_assay_response_count: null,
61
+ pipeline_program_count: null,
62
+ pipeline_active_program_count: null,
63
+ pipeline_max_phase: null
64
+ )
65
+ ```
66
+
@@ -8,7 +8,7 @@
8
8
  | **grain** | **String** | | [optional] |
9
9
  | **object_type** | **String** | | [optional] |
10
10
  | **id** | **String** | | [optional] |
11
- | **scope** | [**BiomarkerCdxAssertionsResponseScope**](BiomarkerCdxAssertionsResponseScope.md) | | [optional] |
11
+ | **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
12
12
  | **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
13
13
  | **rows** | [**Array<BiomarkerBqpAssertionsRow>**](BiomarkerBqpAssertionsRow.md) | | |
14
14
  | **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
@@ -21,8 +21,8 @@
21
21
  | **source_credit** | **String** | | [optional] |
22
22
  | **withheld_tiers** | **Array<String>** | | [optional] |
23
23
  | **withheld_columns** | **Array<String>** | | [optional] |
24
- | **freshness** | [**BiomarkerCdxAssertionsResponseFreshness**](BiomarkerCdxAssertionsResponseFreshness.md) | | [optional] |
25
- | **build** | [**BiomarkerCdxAssertionsResponseBuild**](BiomarkerCdxAssertionsResponseBuild.md) | | [optional] |
24
+ | **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
25
+ | **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
26
26
  | **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
27
27
  | **restriction** | **Hash<String, Object>** | | [optional] |
28
28